Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Joint Metastasis Research Society-AACR Conference on Metastasis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

[Cancer Research 48, 4135-4143, August 1, 1988]
© 1988 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weinstein, I. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weinstein, I. B.

The Origins of Human Cancer: Molecular Mechanisms of Carcinogenesis and Their Implications for Cancer Prevention and Treatment—Twenty-seventh G. H. A. Clowes Memorial Award Lecture1

I. Bernard Weinstein

Comprehensive Cancer Center, Institute of Cancer Research, Department of Medicine, and School of Public Health, Columbia University, New York, New York 10032

Epidemiological studies provide evidence that environmental factors (external agents such as chemicals, radiation, and viruses) play a major role in the causation of the majority of human tumors. This is a highly optimistic message, since it implies that cancer is largely a preventable disease. To meet this challenge we must, however, understand the mechanisms of cancer causation at the cellular and molecular levels and, in a parallel effort, develop new laboratory methods that can be used to identify specific causative agents in humans. The approach must be comprehensive since it is likely that human cancers are due to complex interactions between multiple factors, including the combined actions of chemical and viral agents. This paper reviews recent studies from our laboratory and studies by other investigators related to these themes.

A major principle in studies on mechanisms of carcinogenesis is that the process proceeds through multiple discernible stages, including initiation, promotion, and progression. It is likely that the transition between these stages is driven by different environmental and endogenous factors and involves different biochemical mechanisms and genetic elements. Several types of chemicals initiate the carcinogenic process by yielding highly reactive species that bind covalently to cellular DNA. Our group has elucidated the details of this process with two groups of compounds, aromatic amines and polycyclic aromatic hydrocarbons, emphasizing how these agents distort the conformation of DNA and its functions during DNA replication and transcription. The implications of these findings with respect to oncogene activation, DNA amplification, gene transposition, and chromosome translocations are discussed. Our studies on tumor promotion have concentrated on the mechanisms of action of the potent tumor promoter 12-O-tetradecanoylphorbol-13-acetate. Studies from several laboratories indicate that this agent and related compounds produce their effects by activating a specific cellular enzyme, protein kinase C (PKC). This produces a cascade of events which include alterations in the function of membrane-associated ion channels and receptors, alterations in gene expression and, ultimately, changes in cellular differentiation and proliferation. Recent studies on the isolation and stable overexpression of a cloned DNA sequence that encodes PKC are described. The results obtained provide direct evidence that PKC plays a critical role in growth control. The possible role of PKC, and other mediators of signal transduction pathways, in the origin of certain human cancers is also discussed.

Finally, this paper discusses how insights into molecular mechanisms of carcinogenesis provide new approaches to the detection of specific causes of human cancer, using an approach termed "molecular cancer epidemiology," and also new strategies for cancer prevention and treatment.

1 Financial support of this research was provided by the National Cancer Institute, the American Cancer Society, the Alma Toorock Memorial for Cancer Research, and the National Foundation for Cancer Research. Presented at the Seventy-eighth Annual Meeting of the American Association for Cancer Research, May 21, 1987, in Atlanta, GA.

Received 4/11/88. Accepted 5/ 3/88.




This article has been cited by other articles:


Home page
Cancer Res.Home page
S. Altuwaijri, H.-K. Lin, K.-H. Chuang, W.-J. Lin, S. Yeh, L. A. Hanchett, M. M. Rahman, H.-Y. Kang, M.-Y. Tsai, Y. Zhang, et al.
Interruption of Nuclear Factor {kappa}B Signaling by the Androgen Receptor Facilitates 12-O-Tetradecanoylphorbolacetate-Induced Apoptosis in Androgen-sensitive Prostate Cancer LNCaP Cells
Cancer Res., November 1, 2003; 63(21): 7106 - 7112.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
I.B. Weinstein
Disorders in cell circuitry during multistage carcinogenesis: the role of homeostasis
Carcinogenesis, May 1, 2000; 21(5): 857 - 864.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
K. Gasiorowski and B. Brokos
Evaluation of antimutagenic effect of todralazine in cultured lymphocytes
Mutagenesis, March 1, 2000; 15(2): 137 - 141.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Takada, M. Hachiya, Y. Osawa, Y. Hasegawa, K. Ando, Y. Kobayashi, and M. Akashi
12-O-tetradecanoylphorbol-13-acetate-induced Apoptosis Is Mediated by Tumor Necrosis Factor alpha in Human Monocytic U937 Cells
J. Biol. Chem., October 1, 1999; 274(40): 28286 - 28292.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Huang, W.-Y. Ma, J. Li, A. Goranson, and Z. Dong
Requirement of Erk, but Not JNK, for Arsenite-induced Cell Transformation
J. Biol. Chem., May 21, 1999; 274(21): 14595 - 14601.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. T. Waldron, T. Iglesias, and E. Rozengurt
The Pleckstrin Homology Domain of Protein Kinase D Interacts Preferentially with the eta  Isoform of Protein Kinase C
J. Biol. Chem., April 2, 1999; 274(14): 9224 - 9230.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
S. D. Hursting, T. J. Slaga, S. M. Fischer, J. DiGiovanni, and J. M. Phang
Mechanism-Based Cancer Prevention Approaches: Targets, Examples, and the Use of Transgenic Mice
J Natl Cancer Inst, February 3, 1999; 91(3): 215 - 225.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. L. Kelly, Y. Tang, N. Rosensweig, S. Clejan, and B. S. Beckman
Granulocyte-Macrophage Colony-Stimulating Factor Rescues TF-1 Leukemia Cells From Ionizing Radiation-Induced Apoptosis Through a Pathway Mediated by Protein Kinase Calpha
Blood, July 15, 1998; 92(2): 416 - 424.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Huang, W.-Y. Ma, M. R. Young, N. Colburn, and Z. Dong
Shortage of mitogen-activated protein kinase is responsible for resistance to AP-1 transactivation and transformation in mouse JB6 cells
PNAS, January 6, 1998; 95(1): 156 - 161.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Iglesias and E. Rozengurt
Protein Kinase D Activation by Mutations within Its Pleckstrin Homology Domain
J. Biol. Chem., January 2, 1998; 273(1): 410 - 416.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. L. Zugaza, R. T. Waldron, J. Sinnett-Smith, and E. Rozengurt
Bombesin, Vasopressin, Endothelin, Bradykinin, and Platelet-derived Growth Factor Rapidly Activate Protein Kinase D through a Protein Kinase C-dependent Signal Transduction Pathway
J. Biol. Chem., September 19, 1997; 272(38): 23952 - 23960.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. G. Kazanietz, S. Wang, G. W. A. Milne, N. E. Lewin, H. L. Liu, and P. M. Blumberg
Residues in the Second Cysteine-rich Region of Protein Kinase C [IMAGE] Relevant to Phorbol Ester Binding as Revealed by Site-directed Mutagenesis
J. Biol. Chem., September 15, 1995; 270(37): 21852 - 21859.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Seedorf, M. Shearman, and A. Ullrich
Rapid and Long Term Effects of Protein Kinase C on Receptor Tyrosine Kinase Phosphorylation and Degradation
J. Biol. Chem., August 11, 1995; 270(32): 18953 - 18960.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
R Parsons, G. Li, M Longley, P Modrich, B Liu, T Berk, Hamilton SR, K. Kinzler, and B Vogelstein
Mismatch repair deficiency in phenotypically normal human cells
Science, May 5, 1995; 268(5211): 738 - 740.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
J. Van Lint, J. Sinnett-Smith, and E. Rozengurt
Expression and Characterization of PKD, a Phorbol Ester and Diacylglycerol-stimulated Serine Protein Kinase
J. Biol. Chem., January 20, 1995; 270(3): 1455 - 1461.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Borner, M. Ueffing, S. Jaken, P. J. Parker, and I. B. Weinstein
Two Closely Related Isoforms of Protein Kinase C Produce Reciprocal Effects on the Growth of Rat Fibroblasts
J. Biol. Chem., January 6, 1995; 270(1): 78 - 86.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
L. Dumenco, E Allay, K Norton, and S. Gerson
The prevention of thymic lymphomas in transgenic mice by human O6-alkylguanine-DNA alkyltransferase
Science, January 8, 1993; 259(5092): 219 - 222.
[Abstract] [PDF]


Home page
ScienceHome page
I. Weinstein
Mitogenesis is only one factor in carcinogenesis
Science, January 25, 1991; 251(4992): 387 - 388.
[PDF]


Home page
ScienceHome page
F. Perera
Carcinogens and human health: Part 1
Science, December 21, 1990; 250(4988): 1644 - 1646.
[PDF]


Home page
ScienceHome page
D Julius, T. Livelli, T. Jessell, and R Axel
Ectopic expression of the serotonin 1c receptor and the triggering of malignant transformation
Science, June 2, 1989; 244(4908): 1057 - 1062.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1988 by the American Association for Cancer Research.